Long-Term Time Series Forecasting and Updates on Survival Analysis of Glioblastoma Multiforme: A 1975-2018 Population-Based Study

被引:15
|
作者
Alexopoulos, Georgios [1 ,2 ]
Zhang, Justin [2 ]
Karampelas, Ioannis [3 ]
Patel, Mayur [2 ]
Kemp, Joanna [1 ,2 ]
Coppens, Jeroen [1 ,2 ]
Mattei, Tobias A. [1 ,2 ]
Mercier, Philippe [1 ,2 ]
机构
[1] St Louis Univ Hosp, Dept Neurosurg, St Louis, MO 63104 USA
[2] St Louis Univ, Sch Med, St Louis, MO 63103 USA
[3] Banner Neurol Surg Clin, Dept Neurosurg, Greeley, CO USA
关键词
Epidemiologic studies; Glioblastoma incidence; Survival analysis; Population-based study; Time series forecasting; Glioblastoma multiforme; ACCELERATED FAILURE-TIME; MODELS;
D O I
10.1159/000522611
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: Glioblastomas multiforme (GBMs) are the most common primary CNS tumors. Epidemiologic studies have investigated the effect of demographics on patient survival, but the literature remains inconclusive. Methods: This study included all adult patients with intracranial GBMs reported in the surveillance epidemiology and end results (SEER)-9 population database (1975-2018). The sample consisted of 32,746 unique entries. We forecast the annual GBM incidence in the US population through the year 2060 using time series analysis with autoregressive moving averages. A survival analysis of the GBM-specific time to death was also performed. Multivariate Cox proportional hazards (PH) regression revealed frank violations of the PH assumption for multiple covariates. Parametric models best described the GBM population's survival pattern; the results were compared to the semi-parametric analysis and the published literature. Results: We predicted an increasing GBM incidence, which demonstrated that by the year 2060, over 1,800 cases will be reported annually in the SEER. All eight demographic variables were significant in the univariable analysis. The calendar year 2005 was the cutoff associated with an increased survival probability. A male survival benefit was eliminated in the year-adjusted Cox. Infratentorial tumors, nonmetropolitan areas, and White patient race were the factors erroneously associated with survival in the multivariate Cox analysis. Accelerated Failure Time (AFT) lognormal regression was the best model to describe the survival pattern in our patient population, identifying age >30 years old as a poor prognostic and patients >70 years old as having the worst survival. Annual income >USD 75,000 and supratentorial tumors had good prognostics, while surgical intervention provided the strongest survival benefit. Conclusions: Annual GBM incidence rates will continue to increase by almost 50% in the upcoming 30 years. Cox regression analysis should not be utilized for time-to-event predictions in GBM survival statistics. AFT lognormal distribution best describes the GBM-specific survival pattern, and as an inherent population characteristic, it should be implemented by researchers for future studies. Surgical intervention provides the strongest survival benefit, while patient age >70 years old is the worst prognostic. Based on our study, the demographics such as gender, race, and county type should not be considered as meaningful prognostics when designing future trials.
引用
收藏
页码:75 / 89
页数:15
相关论文
共 50 条
  • [1] Long-term glioblastoma multiforme survivors: A population-based study in Alberta from 1975 to 1991
    Scott, JN
    Rewcastle, NB
    Brasher, P
    MacKinnon, J
    Hagen, N
    Forsyth, P
    Cairncross, JG
    Fulton, D
    ANNALS OF NEUROLOGY, 1997, 42 (03) : T279 - T279
  • [2] Long-term glioblastoma multiforme survivors: a population-based study
    Scott, JN
    Rewcastle, NB
    Brasher, PMA
    Fulton, D
    Hagen, NA
    MacKinnon, JA
    Sutherland, G
    Cairncross, JG
    Forsyth, P
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1998, 25 (03) : 197 - 201
  • [3] Conditional Probability of Long-Term Survival in Glioblastoma A Population-Based Analysis
    Johnson, Derek R.
    Ma, Daniel J.
    Buckner, Jan C.
    Hammack, Julie E.
    CANCER, 2012, 118 (22) : 5608 - 5613
  • [4] Which glioblastoma multiforme patient will become a long-term survivor? A population-based study
    Scott, JN
    Rewcastle, NB
    Brasher, PMA
    Fulton, D
    MacKinnon, JA
    Hamilton, M
    Cairncross, JG
    Forsyth, P
    ANNALS OF NEUROLOGY, 1999, 46 (02) : 183 - 188
  • [5] A clinicopathological and molecular analysis of glioblastoma multiforme with long-term survival
    Das, Prasenjit
    Puri, Tarun
    Jha, Prerana
    Pathak, Pankaj
    Joshi, Nikhil
    Suri, Vaishali
    Sharma, Mehar Chand
    Sharma, Bhawani S.
    Mahapatra, A. K.
    Suri, Ashish
    Sarkar, Chitra
    JOURNAL OF CLINICAL NEUROSCIENCE, 2011, 18 (01) : 66 - 70
  • [6] Analysis of MGMT methylation and long-term survival in patients with glioblastoma multiforme
    Sibenaller, Zita A.
    Allen, Carey L.
    Kilburg, Craig J.
    Ryken, Timothy C.
    NEURO-ONCOLOGY, 2006, 8 (04) : 463 - 463
  • [7] Changing epidemiology of esophageal cancer: A population-based study over 43 years (1975-2018)
    Bien, Jeffrey
    Nguyen, Theresa Hoang-Anh
    Aljehani, Mayada
    Lee, Jerry S. H.
    Wang, David H.
    Lin, Albert Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [8] GBM, are there long-term survivors with glioblastoma? Results of a population-based study
    Mahmud, A
    Tonita, J
    Robinson, C
    Chalchal, I
    Shiels, R
    Brundage, M
    RADIOTHERAPY AND ONCOLOGY, 2005, 76 : S42 - S42
  • [9] Long-term Survival of Six Patients with Glioblastoma Multiforme: Case Series and Review of the Literature
    Omidvari, Shapour
    Nasrolahi, Hamid
    Kani, Amir Abbas
    Ahmadloo, Niloofar
    Mosalaei, Ahmad
    Mohammadianpanah, Mohammad
    Ansari, Mansour
    MIDDLE EAST JOURNAL OF CANCER, 2012, 3 (2-3) : 79 - 83
  • [10] Long-term survival in a population-based study on status epilepticus
    Leitinger, M.
    Giovannini, G.
    Rustamova, C.
    Pilz, G.
    Kalss, G.
    Novak, H.
    Rossini, F.
    Hoeler, J.
    Kuchukhidze, G.
    Astner-Rohracher, A.
    Leitner, U.
    Mauritz, M.
    Poppert, K. N.
    Toma, A.
    Crespo-Pimentel, B.
    Bosque-Varela, P.
    Zimmermann, G.
    Asani, N.
    Granbichler, C.
    Neuray, C.
    Kreidenhuber, R.
    Dobesberger, J.
    Florea, C.
    Meletti, S.
    Siebert, U.
    Trinka, E.
    EPILEPSIA, 2024, 65 : 504 - 505